Cytosorbents Corporation (NASDAQ:CTSO) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET
Company Participants
Adanna Alexander – Investor Relations
Phillip Chan – Chief Executive Officer
Makis Deliargyris – Chief Medical Officer
Pete Mariani – Chief Financial Officer
Conference Call Participants
Michael Sarcone – Jefferies
Sean Lee – H.C. Wainwright
Michael Kim – Zacks Small-Capital Research
Operator
Good afternoon, ladies and gentlemen, and welcome to the CytoSorbents First Quarter 2025 Earnings Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This call is being recorded on [Thursday, May 8, 2025] (ph).
I would now like to turn the conference over to Mr. Adanna Alexander. Please go ahead.
Adanna Alexander
Thank you, Constantine, and good afternoon, everyone. Welcome to CytoSorbents’ first quarter 2025 financial results and recent business highlights conference call.
Joining me today from the company for prepared remarks are Dr. Phillip Chan, Chief Executive Officer; Dr. Makis Deliargyris, Chief Medical Officer; and Pete Mariani, Chief Financial Officer.
Before I turn the call over to Dr. Chan, I’d like to remind listeners that during the call, management’s prepared remarks may contain forward-looking statements, which are subject to risks and uncertainties. Management may make additional forward-looking statements in response to your questions today. Therefore, the company claims protection under the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.
Actual results may differ from results discussed today. The forward-looking statements we make reflect our views and estimates as of today, May 14, 2025, and we assume no obligation to update these projections in the future as market conditions change.
During today’s call, we will have an overview presentation covering the operating and financial highlights for the first quarter 2025. Following the presentation, we will
Read the full article here